ORKA
Oruka Therapeutics Inc.

225
Mkt Cap
$1.55B
Volume
1.59M
52W High
$41.19
52W Low
$5.49
PE Ratio
-17.25
ORKA Fundamentals
Price
$40.00
Prev Close
$31.99
Open
$32.84
50D MA
$32.78
Beta
1.12
Avg. Volume
339,262.59
EPS (Annual)
-$2.31
P/B
4.16
Rev/Employee
$0.00
$1,050.38
Loading...
Loading...
News
all
press releases
Barclays Issues Positive Forecast for Oruka Therapeutics (NASDAQ:ORKA) Stock Price
Barclays raised their price objective on Oruka Therapeutics from $48.00 to $50.00 and gave the company an "overweight" rating in a research note on Friday...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Price Target Raised to $72.00
Stifel Nicolaus boosted their target price on shares of Oruka Therapeutics from $47.00 to $72.00 and gave the stock a "buy" rating in a research report on Friday...
MarketBeat·12h ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Given "Buy" Rating at BTIG Research
BTIG Research restated a "buy" rating and set a $73.00 price objective on shares of Oruka Therapeutics in a report on Friday...
MarketBeat·12h ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Sets New 52-Week High on Strong Earnings
Oruka Therapeutics (NASDAQ:ORKA) Hits New 12-Month High on Better-Than-Expected Earnings...
MarketBeat·12h ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Receives "Outperform" Rating from Wedbush
Wedbush reaffirmed an "outperform" rating and issued a $45.00 price objective on shares of Oruka Therapeutics in a research report on Friday...
MarketBeat·13h ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Earns "Buy" Rating from Guggenheim
Guggenheim reiterated a "buy" rating and issued a $60.00 price target on shares of Oruka Therapeutics in a report on Friday...
MarketBeat·13h ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Issues Quarterly Earnings Results, Beats Estimates By $0.16 EPS
Oruka Therapeutics (NASDAQ:ORKA - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.45) earnings per share (EPS) for the quarter, topping analysts...
MarketBeat·1d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 7.8% - Time to Sell?
Oruka Therapeutics (NASDAQ:ORKA) Stock Price Down 7.8% - Should You Sell...
MarketBeat·1d ago
News Placeholder
Oruka Therapeutics (NASDAQ:ORKA) Lowered to "Sell" Rating by Wall Street Zen
Wall Street Zen lowered shares of Oruka Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·6d ago
News Placeholder
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Short Interest Down 17.2% in February
Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) saw a significant decrease in short interest during the month of February. As of February 13th, there was short interest totaling 4,062,540...
MarketBeat·11d ago
<
1
2
...
>

Latest ORKA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.